Maternal Lifestyle Factors and Risk for Ventricular Septal Defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 2, 2004, Pages 59-64

  Williams, Laura J ^a   Correa, Adolfo ^a   Rasmussen, Sonja ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alcohol; Lifestyle factors; Marijuana; Ventricular septal defects

Indexed keywords

ALCOHOL; CANNABIS; ILLICIT DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CALCULATION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FETUS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROGENY; STANDARDIZATION; UNITED STATES;

ADOLESCENT; ADULT; ALCOHOLS; BULIMIA; CANNABIS; CASE-CONTROL STUDIES; COCAINE; FEMALE; GEORGIA; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; LIFE STYLE; MOTHERS; PREGNANCY; RISK FACTORS; SELF DISCLOSURE; SMOKING;

CANNABIS; CANNABIS SATIVA;

EID: 1542336760     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10145     Document Type: Article

References (47)

1. Abelson HI, Miller JD. 1985. A decade of trends in cocaine use in the household population. NIDA Res Monogr 61:35-49.
2. Adams MA, Mulinare J, Dooley K. 1989. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol 14:432-442.
3. Adickes ED, Mollner TJ, Makoid MC. 1993. Ethanol-induced teratogenic alteration in developing cardiomyocytes in culture. Alcohol Alcohol Suppl 2:283-288.
4. Ammenheuser MM, Berenson AB, Babiak AE, et al. 1998. Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns. Mutat Res 403:55-64.
5. Bingol N, Fuchs M, Diaz V, et al. 1987. Teratogenicity of cocaine in humans. J Pediatr 110:93-96.
6. Botto LD, Correa A, Erickson JD. 2001. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107:E32.
7. Brickner ME, Hillis LD, Lange RA. 2000. Congenital heart disease in adults. N Engl J Med 342:256-263.
8. Centers for Disease Control and Prevention. 1981. Current trends: ventricular septal defect. MMWR Morb Mortal Wkly Rep 30:609-610.
9. Centers for Disease Control and Prevention. 1996. Population-based prevalence of perinatal exposure to cocaine-Georgia, 1994. MMWR Morb Mortal Wkly Rep 45:887-891.
10. Centers for Disease Control and Prevention. 1998. Trends in infant mortality attributable to birth defects-United States, 1980-1995. MMWR Morb Mortal Wkly Rep 47:773-778.
11. Champion RA, Bell DS. 1980. Monitoring trends in drug use. Int J Addict 15:375-390.
12. Christmas JR, Knisley JS, Dawson KS, et al. 1992. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstet Gynecol 80:750-754.
13. Day N, Sambamoorthi U, Taylor P, et al. 1991. Prenatal marijuana use and neonatal outcomes. Neurotoxicol Teratol 13:329-334.
14. Erickson JD, Mulinare J, McClain PW, et al. 1984. Vietnam veterans' risks for fathering babies with birth defects. Atlanta: Centers for Disease Control and Prevention. pp 1-67.
15. Ewing CK, Loffredo CA, Beaty TH. 1997. Paternal risk factors for isolated membranous ventricular septal defects. Am J Med Genet 71:42-46.
16. Ferencz C, Correa Villasenor A. 1991. Epidemiology of cardiovascular malformations: the state of the art. Cardiol Young 1:264-284.
17. Ferencz C, Loffredo CA, Correa-Villasenor A, editors. 1997. Perspectives in pediatric cardiology. Vol. 5. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study 1981-1989. New York: Futura Publishing Company, Inc. pp 124-162.
18. Frank DA, Zuckerman BS, Amaro H, et al. 1988. Cocaine use during pregnancy: prevalence and correlates. Pediatrics 82:888-895.
19. Fried PA. 1991. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol 15:280-287.
20. Gibson GT, Baghurst PA, Colley DP. 1983. Maternal alcohol, tobacco and cannabis consumption and outcomes of pregnancy. Aust N Z J Obstet Gynaecol 23:15-19.
21. Graham TP Jr, Gutgesell HP. 1995. Ventricular Septal Defects. In: Emmanouilides GC, editor. Moss and Andrews heart disease in infants, children and adolescents: including the fetus and young adult, 5th ed. Baltimore: Williams and Wilkins. pp 724-744.
22. Graham TP, Jr, Gutgesell HP. 1995. Moss and Adams' heart disease in infants, children, and adolescents: including the fetus and young adult. In: Emmanouilides GC, editor. 5th ed. Baltimore: Williams & Wilkins. pp. 724-744.
23. Greene MH, Nightingale SL, DuPont RL. 1975. Evolving patterns of drug use. Ann Intern Med 83:402-411.
24. Hatch EE, Bracken MB. 1986. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 124:986-93.
25. Hatch MC, Misra D, Kabat GC, Kartzmer S. 1991. Proxy respondents in reproductive research: a comparison of self- and partner-reported data. Am J Epidemiol 133:826-831.
26. Hillard CJ. 2000. Endocannabinoids and vascular function. J Pharmacol Exp Ther 294:27-32.
27. Hingson R, Alpert JJ, Day N, et al. 1982. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 70:539-546.
28. Hoffman JIE, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 30:1890-1900.
29. Honein MA, Paulozzi LJ. 1999. Birth defects surveillance: assessing the "gold standard." Am J Public Health 89:1238-1240.
30. Hutchins E, DiPietro J. 1997. Psychosocial risk factors associated with cocaine use during pregnancy: a case-control study. Obstet Gynecol 90:142-147.
31. Lester BM, ElSohly M, Wright LL, et al. 2001. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 107:309-317.
32. Lewis DA, Loffredo CA, Correa-Villasenor A, et al. 1996. Descriptive epidemiology of membranous and muscular ventricular septal defects in the Baltimore-Washington Infant Study. Cardiol Young 6:281-290.
33. Lindsay MK, Carmichael S, Peterson H, et al. 1997. Correlation between self-reported cocaine use and urine toxicology in an inner-city prenatal population. J Natl Med Assoc 89:57-60.
34. Lipshultz SE, Frassica JJ, Orav J. 1991. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 118:44-51.
35. Little BB, Snell LM, Klein VR, Gilstrap LC III. 1989. Cocaine abuse during pregnancy: maternal and fetal implications. Obstet Gynecol 73:157-160.
36. Menegola E, Broccia ML, Di Renzo F, Giavini E. 2001. Acetaldehyde in vitro exposure and apoptosis: a possible mechanism of teratogenesis. Alcohol 23:35-39.
37. Nelson LM, Longstreth WT Jr, Koepsell TD, et al. 1994. Completeness and accuracy of interview data from proxy respondents: demographic, medical, and life-style factors. Epidemiology 5:204-217.
38. O'Connell CM, Fried PA. 1984. An investigation of prenatal cannabis exposure and minor physical anomalies in a low risk population. Neurobehav Toxicol Teratol 6:345-350.
39. Passaro KT, Noss J, Savitz DA, et al. 1997. Agreement between self and partner reports of paternal drinking and smoking. Int J Epidemiol 26:315-320.
40. Qazi QH, Mariano E, Milman DH, et al. 1985. Abnormalities in offspring associated with prenatal marihuana exposure. Dev Pharmacol Ther 8:141-148.
41. Savitz DA, Schwingl PJ, Keels MA. 1991. Influence of paternal age, smoking, and alcohol consumption on congenital anomalies. Teratology 44:429-440.
42. Shaw GM, Malcoe LH, Lammer EJ. 1991. Maternal use of cocaine during pregnancy and congenital cardiac anomalies. J Pediatr 118:167-168.
43. Tennes K, Avitable N, Backard C, et al. 1985, Marijuana: prenatal and postnatal exposure in the human. NIDA Res Monogr 59:48-60.
44. Tikkanen J, Heinonen OP. 1991. Risk factors for ventricular septal defect in Finland. Public Health 105:99-112.
45. Torfs CP, Velie EM, Oechsli FW, et al. 1994. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 50:44-53.
46. Zimmerman S, Zimmerman AM. 1990-1991. Genetic effects of marijuana. Int J Addict 25:19-33.
47. Zuckerman B, Frank DA, Hingson R, et al. 1989. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762-768.